Skip to main content

Written question asked by Bishop of St Albans (Bishops (affiliation)) on Tuesday, 26 January 2021, in the House of Lords. It was due for an answer on Tuesday, 9 February 2021. It was answered by Lord Callanan (Conservative) on Tuesday, 9 February 2021 on behalf of the Department for Business, Energy and Industrial Strategy.


Coronavirus: Vaccination

Question

To ask Her Majesty's Government how many COVID-19 vaccination doses they have ordered in total; whether they intend to order more doses than the number required to vaccinate the population of the UK; and if so, what plans they have to ensure that any surplus doses are used effectively.

Answer

The UK Government has secured early access to 457 million vaccines doses through agreements with eight separate vaccine developers. This includes agreements with BioNTech/Pfizer, Oxford/AstraZeneca, GlaxoSmithKline and Sanofi Pasteur, Novavax, Janssen, Valneva and Moderna.

The Government continues to monitor the landscape of COVID-19 vaccine development, both here in the UK and internationally, and will keep the situation under review.

My Rt. Hon. Friend the Prime Minister has made clear that equitable access is an integral part of the UK’s approach to vaccine development and distribution. The UK is working with international partners to support vaccine development, manufacturing scale-up and future distribution to meet both domestic and international needs.


Secondary information

Type
Written question
Reference
HL12612
Session
2019-21
Subjects
Vaccination Coronavirus
Contains statistics
Yes
Link
View this Written question on www.parliament.uk